Henry Schein, Inc. (NASDAQ:HSIC) Shares Sold by Centerstone Investors LLC

Centerstone Investors LLC decreased its position in Henry Schein, Inc. (NASDAQ:HSIC) by 27.2% during the 4th quarter, Holdings Channel reports. The fund owned 51,991 shares of the company’s stock after selling 19,383 shares during the quarter. Henry Schein comprises about 5.3% of Centerstone Investors LLC’s holdings, making the stock its 6th biggest position. Centerstone Investors LLC’s holdings in Henry Schein were worth $3,598,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also made changes to their positions in the company. Smartleaf Asset Management LLC boosted its holdings in Henry Schein by 23.2% in the 4th quarter. Smartleaf Asset Management LLC now owns 759 shares of the company’s stock valued at $52,000 after purchasing an additional 143 shares in the last quarter. Guggenheim Capital LLC boosted its stake in shares of Henry Schein by 2.5% in the fourth quarter. Guggenheim Capital LLC now owns 6,428 shares of the company’s stock valued at $445,000 after buying an additional 159 shares in the last quarter. CIBC Asset Management Inc raised its position in Henry Schein by 1.0% in the fourth quarter. CIBC Asset Management Inc now owns 17,849 shares of the company’s stock worth $1,235,000 after acquiring an additional 169 shares in the last quarter. Metis Global Partners LLC lifted its holdings in Henry Schein by 4.7% in the fourth quarter. Metis Global Partners LLC now owns 4,203 shares of the company’s stock valued at $291,000 after acquiring an additional 187 shares during the period. Finally, Sanctuary Advisors LLC boosted its position in shares of Henry Schein by 5.0% during the 4th quarter. Sanctuary Advisors LLC now owns 4,253 shares of the company’s stock worth $294,000 after purchasing an additional 203 shares in the last quarter. 96.62% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several research analysts have weighed in on the stock. UBS Group lowered their target price on shares of Henry Schein from $83.00 to $80.00 and set a “neutral” rating on the stock in a research report on Wednesday, February 26th. Wells Fargo & Company dropped their price objective on Henry Schein from $80.00 to $75.00 and set an “equal weight” rating for the company in a research note on Tuesday, May 6th. Barrington Research cut their price objective on Henry Schein from $90.00 to $86.00 and set an “outperform” rating for the company in a research report on Tuesday, May 6th. Piper Sandler lowered their target price on Henry Schein from $83.00 to $77.00 and set an “overweight” rating on the stock in a report on Wednesday, April 30th. Finally, Wall Street Zen downgraded Henry Schein from a “buy” rating to a “hold” rating in a research report on Thursday, April 17th. Six investment analysts have rated the stock with a hold rating, five have given a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat, Henry Schein currently has an average rating of “Moderate Buy” and an average price target of $79.30.

Henry Schein Stock Down 1.0%

Shares of NASDAQ HSIC opened at $71.33 on Friday. The stock has a fifty day moving average price of $67.46 and a 200 day moving average price of $71.49. The company has a current ratio of 1.42, a quick ratio of 0.82 and a debt-to-equity ratio of 0.46. Henry Schein, Inc. has a 12-month low of $60.56 and a 12-month high of $82.49. The company has a market cap of $8.68 billion, a P/E ratio of 29.35, a P/E/G ratio of 2.13 and a beta of 0.87.

Henry Schein (NASDAQ:HSIC) last posted its quarterly earnings data on Monday, May 5th. The company reported $1.15 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.11 by $0.04. The company had revenue of $3.17 billion for the quarter, compared to analyst estimates of $3.24 billion. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The business’s quarterly revenue was down .1% on a year-over-year basis. During the same quarter last year, the firm posted $1.10 earnings per share. Research analysts anticipate that Henry Schein, Inc. will post 4.74 EPS for the current fiscal year.

Insider Buying and Selling at Henry Schein

In other news, CEO Bradford C. Connett sold 4,036 shares of Henry Schein stock in a transaction that occurred on Wednesday, March 19th. The stock was sold at an average price of $71.15, for a total value of $287,161.40. Following the completion of the transaction, the chief executive officer now owns 62,688 shares in the company, valued at approximately $4,460,251.20. This trade represents a 6.05% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Philip A. Laskawy sold 2,604 shares of the company’s stock in a transaction that occurred on Wednesday, March 19th. The shares were sold at an average price of $71.04, for a total value of $184,988.16. Following the sale, the director now directly owns 24,805 shares in the company, valued at approximately $1,762,147.20. This represents a 9.50% decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.08% of the stock is currently owned by corporate insiders.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.